Castleman's disease natural history, complications and prognosis

Revision as of 14:15, 21 September 2012 by Raviteja Reddy Guddeti (talk | contribs) (Created page with "__NOTOC__ {{Castleman's disease}} {{CMG}}; {{AE}} {{RT}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Castleman's disease Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Castleman's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Castleman's disease natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Castleman's disease natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Castleman's disease natural history, complications and prognosis

CDC on Castleman's disease natural history, complications and prognosis

Castleman's disease natural history, complications and prognosis in the news

Blogs on Castleman's disease natural history, complications and prognosis

Directions to Hospitals Treating Castleman's disease

Risk calculators and risk factors for Castleman's disease natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Natural History

Complications

Prognosis

  • Prior to 1996 MCD carried a poor prognosis of about 2 years, due to autoimmune hemolytic anemia and non-Hodgkin's lymphoma which may arise as a result of proliferation of infected cells. The timing of diagnosis, with particular attention to the difficulty of determining the cause of B symptoms without a CT scan and lymph node biopsy, may impact significantly on the prognosis and risk of death. Left untreated, MCD usually gets worse and becomes increasingly difficult and unresponsive to current treatment regimens.
  • HIV patients with multicentric disease have a grave prognosis. They have a less favorable clinical course and tend to develop Kaposi sarcoma and even plasmablastic non-Hodgkin lymphoma.

References

de:Morbus Castleman

Template:WS